|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||77.70 - 79.30|
|52 Week Range||42.50 - 98.50|
|Beta (5Y Monthly)||1.54|
|PE Ratio (TTM)||14.22|
|Earnings Date||Jul 30, 2020|
|Forward Dividend & Yield||2.20 (2.78%)|
|Ex-Dividend Date||May 25, 2020|
|1y Target Est||110.13|
European stocks opened flat on Wednesday, with investors weighing up a fresh batch of earnings and data showing Germany factory orders saw the biggest drop record in March. The Stoxx Europe 600 index slipped 0.1% to 334.96, after the index broke a three-session losing streak on Tuesday with a more than 2% gain. Investors continue to keep a concerned eye on the pandemic, after news that the U.K. has now replaced Italy with the biggest death toll in Europe. A fresh batch of earnings showed companies continue to struggle with virus fallout. Shares of BMW fell nearly 5% after warning of significantly lower profit in 2020, while shares of chemical group Arkema SA sank 4% after posting revenue and earnings falls. U.S. equity futures headed the other direction, with Dow futures climbing 179 points after President Donald Trump said the country would have to keep reopening businesses even if it means more deaths due to the coronavirus.
Those holding Arkema (EPA:AKE) shares must be pleased that the share price has rebounded 36% in the last thirty days...
Moody's Investors Service ("Moody's") today affirmed the Baa1 long term issuer rating and senior unsecured bond ratings of Evonik Industries AG ("Evonik"). A full list of affected ratings can be found at the end of this press release.
Wall Street closed higher last night, driven by hopes of some lockdown restrictions being lifted, a fall in New York's total hospitalizations and better earnings from consumer giant Johnson & Johnson. In all, it calculates the loss to the world economy over two years at $9 trillion, more than the combined gross domestic product of Germany and Japan.
Unfortunately for some shareholders, the Arkema (EPA:AKE) share price has dived 34% in the last thirty days. That drop...
Many investors define successful investing as beating the market average over the long term. But its virtually certain...
Jurors in the criminal case against the U.S. arm of a French company on Thursday heard it routinely stored combustible chemicals where floodwaters could reach them and failed to alert emergency workers as toxic fires erupted. Arkema SA's U.S. arm failed to relocate chemicals made at the Crosby, Texas, plant ahead of 2017's Hurricane Harvey and every prior storm, charged prosecutor Michael Doyle. Arkema, its U.S. chief executive, Richard Rowe, and the plant manager, Leslie Comardelle, are charged with the toxic releases.
A district judge on Monday delayed opening arguments for a criminal trial accusing a U.S. arm of French chemicals company Arkema SA and its executives for their role in toxic fires following a 2017 hurricane, after prosecution lawyers failed to disclose certain evidence. State judge Belinda Hill found the prosecution improperly withheld evidence that might have benefited the defense.
Moody's Investors Service ("Moody's") today assigned a Baa3 long-term rating to the proposed issuance of E300 million Undated Deeply Subordinated Fixed Rate Resettable Notes (Hybrid) issued by Arkema (Baa1 stable). The rating of Baa3 is two notches lower than Arkema's Baa1 senior unsecured and issuer ratings. This reflects the deeply subordinated position of the proposed Hybrid securities in relation to the existing senior unsecured obligations of Arkema rated Baa1.
Is Arkema S.A. (EPA:AKE) a good dividend stock? How can we tell? Dividend paying companies with growing earnings can...
Moody's Investors Service today upgraded to Baa1 from Baa2 the long-term issuer rating of Arkema and the senior unsecured regular bond rating as well as the senior unsecured medium-term note programme to (P)Baa1 from (P)Baa2. At the same time the junior subordinated bond rating was upgraded to Baa3 from Ba1.
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Arkema and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.